Education
About Us
Working with TipRanks
Follow Us
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
RESEARCH TOOLSreports
Total Valuation
COSMOS Pharmaceutical Corporation has a market cap or net worth of ¥704.30B. The enterprise value is ¥497.35B.
Market Cap¥704.30B
Enterprise Value¥497.35B
Share Statistics
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding80,001,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
COSMOS Pharmaceutical Corporation’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.47%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)8.47%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee175.07M
Profits Per Employee4.44M
Employee Count5,512
Asset Turnover2.02
Inventory Turnover9.01
Valuation Ratios
The current PE Ratio of COSMOS Pharmaceutical Corporation is 20.56. COSMOS Pharmaceutical Corporation’s PEG ratio is 7.95.
PE Ratio20.56
PS Ratio0.00
PB Ratio2.49
Price to Fair Value2.17
Price to FCF67.34
Price to Operating Cash Flow9.65
PEG Ratio7.95
Income Statement
In the last 12 months, COSMOS Pharmaceutical Corporation had revenue of 964.99B and earned 24.45B in profits. Earnings per share was 308.61.
Revenue964.99B
Gross Profit188.31B
Operating Income31.50B
Pretax Income33.72B
Net Income24.45B
EBITDA53.74B
Earnings Per Share (EPS)308.61
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
COSMOS Pharmaceutical Corporation pays an annual dividend of ¥65, resulting in a dividend yield of 0.73%
Dividend Per Share¥65
Dividend Yield0.73%
Payout Ratio8.75%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.28
52-Week Price Change41.87%
50-Day Moving Average8.71K
200-Day Moving Average7.54K
Relative Strength Index (RSI)54.97
Average Volume (3m)337.22K
Important Dates
COSMOS Pharmaceutical Corporation upcoming earnings date is Jul 11, 2025, TBA Not Confirmed.
Last Earnings DateApr 14, 2025
Next Earnings DateJul 11, 2025
Ex-Dividend DateMay 29, 2025
Financial Position
COSMOS Pharmaceutical Corporation as a current ratio of 0.72, with Debt / Equity ratio of 8.62%
Current Ratio0.72
Quick Ratio0.32
Debt to Market Cap0.06
Net Debt to EBITDA-0.34
Interest Coverage Ratio318.19
Taxes
In the past 12 months, COSMOS Pharmaceutical Corporation has paid 9.27B in taxes.
Income Tax9.27B
Effective Tax Rate0.27
Enterprise Valuation
COSMOS Pharmaceutical Corporation EV to EBITDA ratio is 9.02, with an EV/FCF ratio of -763.05.
EV to Sales0.50
EV to EBITDA9.02
EV to Free Cash Flow-763.05
EV to Operating Cash Flow8.78
Balance Sheet
COSMOS Pharmaceutical Corporation has ¥39.13B in cash and marketable securities with ¥25.68B in debt, giving a net cash position of -¥13.45B billion.
Cash & Marketable Securities¥39.13B
Total Debt¥25.68B
Net Cash-¥13.45B
Net Cash Per Share-¥168.17
Tangible Book Value Per Share¥2.91K
Margins
Gross margin is 20.38%, with operating margin of 3.26%, and net profit margin of 2.53%.
Gross Margin20.38%
Operating Margin3.26%
Pretax Margin3.49%
Net Profit Margin2.53%
EBITDA Margin5.57%
EBIT Margin3.50%
Analyst Forecast
The average price target for COSMOS Pharmaceutical Corporation is ¥9,400.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥9,400.00
Price Target Upside5.03% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast6.96%
EPS Growth Forecast-3.96%